This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care

Launched by SHARON-ROSE MALONEY · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether a new tool called the Sodium Management Tool (SMT) can improve the health and comfort of patients receiving hemodialysis. The researchers want to find out if using the SMT can help reduce weight gain between dialysis sessions and make dialysis easier by lowering symptoms like low blood pressure and muscle cramps. To do this, they will compare the usual dialysis treatment with the SMT-assisted treatment.

Eligible participants are adults aged 18 and older who have been on hemodialysis for at least three months and receive dialysis three times a week using a specific machine. During the study, participants will switch between standard dialysis and SMT-assisted dialysis every four weeks. They will have their blood pressure and sodium levels monitored, and they will answer questions about their symptoms and how thirsty they feel. This trial aims to see if the SMT can help patients feel better during their treatments and improve their overall health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Outpatients on hemodialysis for at least three months,
• • Dialysis three times a week, age \>/= 18,
• • dialysis with a Fresenius 6008 Machine,
• • signed informed consent
• Exclusion:
• • Dialysis access with repeated Interruption due to flow problems
• • plasma natrium \< 130 mmol/l, \> 145 mmol/l, pregnancy -